The present invention relates to a cell surface molecules, designated cadherin-like asymmetry proteins ("CLASPs"). In particular, it relates to CLASP-2 polynucleotides, polypeptides, fusion proteins, and antibodies. The invention also relates to methods of modulating an immune response by interfering with CLASP function.